William Blair Investment Management’s Viavi Solutions VIAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-64,028
Closed -$1.13M 507
2021
Q2
$1.13M Sell
64,028
-490,788
-88% -$8.28M ﹤0.01% 312
2021
Q1
$8.71M Sell
554,816
-324,439
-37% -$5.24M 0.03% 301
2020
Q4
$13.2M Buy
879,255
+235,746
+37% +$3.13M 0.04% 256
2020
Q3
$7.55M Buy
643,509
+53,882
+9% +$700K 0.03% 298
2020
Q2
$7.51M Sell
589,627
-289,100
-33% -$3.47M 0.03% 285
2020
Q1
$9.85M Sell
878,727
-38,291
-4% -$521K 0.05% 233
2019
Q4
$13.8M Sell
917,018
-378,091
-29% -$5.66M 0.05% 238
2019
Q3
$18.1M Sell
1,295,109
-85,062
-6% -$1.21M 0.08% 215
2019
Q2
$18.3M Sell
1,380,171
-151,046
-10% -$1.95M 0.08% 214
2019
Q1
$19M Sell
1,531,217
-491,532
-24% -$5.76M 0.08% 217
2018
Q4
$20.3M Buy
2,022,749
+41,398
+2% +$447K 0.1% 189
2018
Q3
$22.5M Sell
1,981,351
-149,436
-7% -$1.61M 0.08% 222
2018
Q2
$21.8M Buy
+2,130,787
New +$21.1M 0.08% 230

Other funds holding VIAV

William Blair Investment Management's VIAV Position: Q3 2021 in Review

William Blair Investment Management sold out of Viavi Solutions (VIAV) in Q3 2021, closing a stake of 64,028 shares — an estimated $1.13M sold.

William Blair Investment Management first reported a position in VIAV in Q2 2018 and held it in 13 quarters. The position peaked at $22.5M in Q3 2018. 299 funds tracked by Wall St. Rank hold VIAV as of Q3 2021.

  • William Blair Investment Management reported no remaining Viavi Solutions position as of Q3 2021 after selling out during the quarter.
  • William Blair Investment Management sold 64,028 Viavi Solutions shares in Q3 2021, an estimated $1.13M.
  • William Blair Investment Management first reported a position in Viavi Solutions in Q2 2018 and held it in 13 quarters.
  • William Blair Investment Management's Viavi Solutions position peaked at $22.5M in Q3 2018.
  • 299 funds tracked by Wall St. Rank held Viavi Solutions as of Q3 2021.

Based on William Blair Investment Management's 13F filing for Q3 2021, filed 10 Nov 2021.